Brooklyn, United States
Mega Aid Compounding Pharmacy, founded in 2007, is a leading player in the Pharmaceutical industry in the United States. Specializing in PCAB-accredited, USP 795/800 compounding, the company prides itself on offering customizable medication solutions without systemic side effects, ensuring improved patient outcomes. Its comprehensive Medication Therapy Management service supports this aim by tracking patient health metrics for continual enhancement.
Mega Aid extends its expertise to a B2B market, providing seamless white-label prescription fulfillment services for Telehealth companies, online prescription platforms, and healthcare facilities. Focus areas include treatments for arthritis, neuropathy, dermatology issues, and more, catering primarily to New York and New Jersey states.
With a strong foundation yet no recent investment history, Mega Aid Compounding Pharmacy presents a unique opportunity for investors to tap into a niche, essential service with room for growth and innovation in personalized medicine.
